Thierry Burnouf: Platelet-Derived Therapies Show Promise for Restoring Neuronal Mitochondrial Function
Thierry Burnouf, Professor of Biomedical Engineering at Taipei Medical University, has shared a post on LinkedIn:
“Our new preprint is now available on bioRxiv: ‘Human Platelet-Derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models’
This work, led by KIRTI GUPTA with contributions from Liling Delila, David Blum, Anup Pandith, and Thierry Burnouf, shows how platelet-derived formulations can restore mitochondrial activity and rebalance redox stress in models of neurodegeneration.
Mitochondrial dysfunction and oxidative stress are common hallmarks of neurodegenerative diseases. We show that two clinically compliant platelet-derived products, a purified platelet lysate (HPPL), and a population of platelet extracellular vesicles (PEVs) rescue mitochondrial activity, reduce oxidative stress, and improve neuronal survival in both cell models and zebrafish embryos.
Data confirm that outdated clinical-grade platelet concentrates can provide a safe, scalable, and locally accessible resource for developing biotherapies, even in countries with limited infrastructure for advanced biologics manufacturing.”
Title: Human Platelet-derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models
Authors: Kirti Gupta, Liling Delila, David Blum, Anup Pandith, Thierry Burnouf
Read the full article here.
More recent insights on Hemostasis Today.
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy